Grand Rounds February 2, 2024: Strategies for Improving Public Understanding of FDA and the Products It Regulates…Why Should We Care, and What Might We Do? (Susan C. Winckler, RPh, Esq)
Rethinking Clinical Trials
FEBRUARY 7, 2024
Winckler, RPh, Esq Chief Executive Officer Reagan-Udall Foundation for the FDA Slides Keywords U.S. Food and Drug Administration, FDA, Misinformation, Communication, Health Information Key Points U.S. Speaker Susan C. Will the strategies pierce the veil of misinformation with these groups?
152 
Let's personalize your content